首页> 外文期刊>International journal of biological sciences >1,25-dihydroxyvitamin D3 Activates MMP13 Gene Expression in Chondrocytes through p38 MARK Pathway
【24h】

1,25-dihydroxyvitamin D3 Activates MMP13 Gene Expression in Chondrocytes through p38 MARK Pathway

机译:1,25-二羟基维生素D3通过p38 MARK途径激活软骨细胞中MMP13基因的表达

获取原文
           

摘要

Osteoarthritis (OA) is the most prevalent degenerative joint disease. The highly regulated balance of matrix synthesis and degradation is disrupted in OA, leading to progressive breakdown of articular cartilage. The molecular events and pathways involved in chondrocyte disfunction of cartilage in OA are not fully understood. It is known that 1,25-dihydroxyvitamin D? (1,25-(OH)2D3) is synthesized by macrophages derived from synovial fluid of patients with inflammatory arthritis. Vitmain D receptor is expressed in chondrocytes within osteoarthritic cartilage, suggesting a contributory role of 1,25-(OH)2D3 in the aberrant behavior of chondrocytes in OA. However, the physiological function of 1,25-(OH)2D3 on chondrocytes in OA remains obscure. Effect of 1,25-(OH)2D3 on gene expression in chondrocytes was investigated in this study. We found that 1,25-(OH)2D3 activated MMP13 expression in a dose-dependent and time-dependent manner, a major enzyme that targets cartilage for degradation. Interestingly, a specific mitogen-activated protein kinase p38 inhibitor SB203580, but not JNK kinase inhibitor SP600125, abrogated 1,25-(OH)2D3 activation of MMP13 expression. 1,25-(OH)2D3-induced increase in MMP13 protein level was in parallel with the phosphorylation of p38 in chondrocytes. To further address the effect of 1,25-(OH)2D3 on MMP13 expression, transfection assays were used to show that 1,25-(OH)2D3 activated the MMP13 promoter reporter expression. MMP13 is known to target type II collagen and aggrecan for degradation, two major components of cartilage matrix. We observed that the treatment of 1,25-(OH)2D3 in chondrocytes results in downregulation of both type II collagen and aggrecan while MMP13 was upregulated. Taken together, we provide the first evidence to demonstrate that 1,25-(OH)2D3 activates MMP13 expression through p38 pathway in chondrocytes. Since MMP13 plays a major role in cartilage degradation in OA, we speculate that the ability of 1,25-(OH)2D3 to potentiate MMP13 expression might facilitate cartilage erosion at the site of inflammatory arthritis.
机译:骨关节炎(OA)是最普遍的变性关节疾病。 OA中破坏了基质合成和降解的高度调节的平衡,导致关节软骨的逐步破坏。尚未完全了解OA中软骨软骨细胞功能异常的分子事件和途径。已知1,25-二羟基维生素D? (1,25-(OH) 2 D 3 )是由炎性关节炎患者滑液衍生的巨噬细胞合成的。 Vitmain D受体在骨关节炎软骨细胞中表达,提示1,25-(OH) 2 D 3 在OA软骨细胞异常行为中起重要作用。然而,1,2-(OH) 2 D 3 在OA的软骨细胞上的生理功能仍然不清楚。研究了1,25-(OH) 2 D 3 对软骨细胞基因表达的影响。我们发现1,25-(OH) 2 D 3 以剂量依赖和时间依赖的方式激活MMP13表达,这是靶向软骨降解的主要酶。有趣的是,特定的促分裂原活化蛋白激酶p38抑制剂SB203580,而不是JNK激酶抑制剂SP600125,废除了MMP13表达的1,25-(OH)2D3激活。 1,25-(OH) 2 D 3 诱导的MMP13蛋白水平增加与软骨细胞中p38的磷酸化平行。为了进一步探讨1,25-(OH) 2 D 3 对MMP13表达的影响,采用转染实验显示1,25-(OH) 2 D 3 激活MMP13启动子报告基因表达。已知MMP13靶向II型胶原蛋白和聚集蛋白聚糖进行降解,这是软骨基质的两个主要成分。我们观察到,软骨细胞中1,25-(OH) 2 D 3 的处理导致II型胶原蛋白和聚集蛋白聚糖的下调,而MMP13上调。综上所述,我们提供了第一个证据来证明1,25-(OH) 2 D 3 通过p38途径激活软骨细胞中的MMP13表达。由于MMP13在OA软骨降解中起主要作用,我们推测1,25-(OH) 2 D 3 增强MMP13表达的能力可能促进软骨侵蚀在炎症性关节炎的部位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号